Skip to content
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Pediatric Endocrinology

Standard of Care: Endocrine Management, Therapies & Screening

At a Glance

Children with 18p deletion syndrome need a proactive, whole-child care plan. Standard care includes growth hormone therapy for short stature, early intervention therapies (speech, physical, and occupational), and baseline screenings to monitor heart, brain, and autoimmune health.

Managing 18p deletion syndrome requires a proactive, “whole-child” approach. Because the condition affects multiple systems, your child will benefit from a team of specialists working together to monitor their growth, development, and long-term health [1][2].

Endocrine Management and Growth

One of the most critical areas of care for children with 18p- is the endocrine system, specifically the pituitary gland.

  • Growth Hormone (GH) Deficiency: Isolated Growth Hormone Deficiency is the most common endocrine issue in 18p- and is a leading cause of short stature [3].
  • GH Therapy: Treatment with recombinant human growth hormone is highly effective and is considered a standard intervention. It has been shown to significantly improve linear growth (height) and can support healthy metabolism [3].
  • Panhypopituitarism: In much rarer cases, the pituitary gland may fail to produce multiple hormones (a condition called panhypopituitarism) [3]. Because of this slight risk, your doctor should also periodically check thyroid and adrenal function [3][1].

Essential Structural Screenings

Certain screenings are recommended to check for structural differences:

  • Brain MRI: This imaging is used to check for holoprosencephaly (HPE), a condition where the brain doesn’t divide correctly into two hemispheres [4]. Severe forms of HPE are usually obvious at birth or on prenatal ultrasounds. However, an MRI may be ordered for a newly diagnosed infant or child to definitively rule out milder forms of HPE [4].
  • Cardiac Evaluation: Children with 18p- have an increased risk for structural congenital heart defects (such as atrial or ventricular septal defects), and occasionally cardiac hypertrophy [5]. A baseline echocardiogram (heart ultrasound) is highly recommended to ensure the heart is structurally sound and functioning normally [5].

Immune and Autoimmune Vigilance

Children with 18p- require monitoring for both immune system deficiencies and overactive immune responses (autoimmunity) [6][7].

  • Immunodeficiency: Some individuals with chromosome 18 deletions experience IgA deficiency, meaning they lack a specific antibody that fights off infections [7]. Your doctor should check baseline immunoglobulin levels (specifically IgA). If deficient, you will need to monitor your child closely for recurrent respiratory or ear infections.
  • Autoimmune Conditions: Recent research has linked the loss of the PTPRM gene to an increased risk of autoimmune conditions, where the body attacks its own tissues [6]. There are documented cases of Type 1 Diabetes and autoimmune thyroid issues (like Graves’ or Hashimoto’s) in 18p- patients [8].

The Power of Early Intervention

Because speech delays and motor challenges are nearly universal, starting therapies as early as possible is the “gold standard” for care [1].

  • Speech Therapy: Focuses on both communication and feeding/swallowing, which is especially important for infants with hypotonia.
  • Physical Therapy (PT): Helps with low muscle tone and reaching motor milestones like crawling or walking [2].
  • Occupational Therapy (OT): Assists with fine motor skills, sensory processing, and daily activities.

Standard of Care Checklist

Use this list to track your child’s health screenings:

Focus Area Specialist Recommended Action
Growth/Hormones Pediatric Endocrinologist Screen for Growth Hormone Deficiency; monitor thyroid/adrenal [3].
Brain Structure Pediatric Neurologist Brain MRI to evaluate for milder forms of holoprosencephaly (HPE) [4].
Heart Health Pediatric Cardiologist Baseline echocardiogram to check for congenital structural defects [5].
Development Developmental Pediatrician Immediate referral for Speech, PT, and OT early intervention [1].
Immune System Primary Care/Endocrine Check baseline IgA levels; screen for Type 1 Diabetes and thyroid antibodies [6][7].
Vision Ophthalmologist Screening for ptosis (drooping eyelids) or vision issues [3].

Return to Home Page

Common questions in this guide

Does my child need growth hormone therapy for 18p deletion syndrome?
Growth hormone deficiency is the most common endocrine issue in 18p deletion syndrome and is a primary cause of short stature. Treatment with recombinant human growth hormone is a standard, highly effective intervention that supports both height and healthy metabolism.
Do you recommend a baseline echocardiogram to check for congenital heart defects?
Children with 18p- have a higher risk of structural congenital heart defects and occasional cardiac hypertrophy. A baseline echocardiogram is highly recommended to ensure your child's heart is structurally sound and functioning normally.
Why does my child need a brain MRI?
Yes, an MRI may be ordered to check for milder forms of holoprosencephaly, a condition where the brain does not completely divide into two hemispheres. While severe forms are usually caught on prenatal ultrasounds, an MRI can definitively rule out milder cases in newly diagnosed children.
At what age should we start annual screenings for Type 1 Diabetes and thyroid antibodies?
Recent research links the loss of the PTPRM gene in 18p deletion syndrome to a higher risk of autoimmune conditions like Type 1 Diabetes and thyroid disease. You should discuss starting baseline screenings for thyroid antibodies and blood sugar levels with your endocrinologist.
Why are early intervention therapies so important for Monosomy 18p?
Because speech delays and low muscle tone are nearly universal in 18p deletion syndrome, starting therapies as early as possible is the gold standard of care. Speech, physical, and occupational therapies help address feeding challenges and ensure children reach communication and motor milestones.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Should we perform a growth hormone stimulation test or a baseline IGF-1 blood test now?
  2. 2.At what age should we start annual screenings for Type 1 Diabetes and thyroid antibodies?
  3. 3.Do you recommend a baseline echocardiogram to check for structural congenital heart defects?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (8)
  1. 1

    Anterior Pituitary Aplasia in an Infant with Ring Chromosome 18p Deletion.

    Bellfield EJ, Chan J, Durrin S, et al.

    Case reports in endocrinology 2016; (2016()):2853178 doi:10.1155/2016/2853178.

    PMID: 27843654
  2. 2

    Spectrum of Movement Disorders in 18p Deletion Syndrome.

    Crosiers D, Blaumeiser B, Van Goethem G

    Movement disorders clinical practice 2019; (6(1)):70-73 doi:10.1002/mdc3.12707.

    PMID: 30746419
  3. 3

    A case of de novo 18p deletion syndrome with panhypopituitarism.

    Yang A, Kim J, Cho SY, et al.

    Annals of pediatric endocrinology & metabolism 2019; (24(1)):60-63 doi:10.6065/apem.2019.24.1.60.

    PMID: 30943682
  4. 4

    [Phenotypic and genetic analysis of a child featuring multiple malformations due to chromosome 18p deletion].

    Pan Q, Hu P, Ou J, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2015; (32(5)):695-9 doi:10.3760/cma.j.issn.1003-9406.2015.05.019.

    PMID: 26418989
  5. 5

    Presentation of an Infant with Chromosome 18p Deletion Syndrome and Asymmetric Septal Hypertrophy.

    Kocaaga A, Yimenicioglu S

    Global medical genetics 2022; (9(2)):179-181 doi:10.1055/s-0042-1743261.

    PMID: 35707779
  6. 6

    Monozygotic triplets with juvenile-onset autoimmunity and 18p microdeletion involving PTPRM.

    Herlin MK, Bernth Jensen JM, Andreasen L, et al.

    Frontiers in genetics 2024; (15()):1437566 doi:10.3389/fgene.2024.1437566.

    PMID: 39359478
  7. 7

    18q Deletion Syndrome Presenting with Late-Onset Combined Immunodeficiency.

    Hashiguchi S, Tomomasa D, Nishikawa T, et al.

    Journal of clinical immunology 2024; (44(7)):154 doi:10.1007/s10875-024-01751-4.

    PMID: 38896123
  8. 8

    18p Deletion Syndrome Associated with Type 1 Diabetes and Hashimoto's Thyroiditis: A Case Report on Autoimmune Disorders and Genetic Factors.

    Oktay MA, Tunca Küçükali ET, Kılınç Uğurlu A, et al.

    Journal of clinical research in pediatric endocrinology 2025; doi:10.4274/jcrpe.galenos.2025.2025-6-5.

    PMID: 41194499

This page provides standard of care guidelines for Monosomy 18p syndrome for educational purposes only. Always consult your pediatric specialists for personalized medical advice, specific screening timelines, and treatment plans for your child.

Get notified when new evidence is published on Monosomy 18p syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.